Journal
INTERNATIONAL REVIEWS OF IMMUNOLOGY
Volume 40, Issue 1-2, Pages 108-125Publisher
TAYLOR & FRANCIS INC
DOI: 10.1080/08830185.2020.1844195
Keywords
Aging; COVID-19; dendritic cells; immunosenescence; SARS-CoV-2
Categories
Ask authors/readers for more resources
SARS-CoV-2, the novel coronavirus responsible for the COVID-19 pandemic, has spread rapidly worldwide affecting over 200 countries. Older individuals are more susceptible, and understanding the interaction between the immune system and the virus, as well as the role of dendritic cells during infection, is crucial for elucidating COVID-19 pathogenesis, risk factors, and development of effective therapies and vaccines.
SARS-CoV-2 is the causative agent of the COVID-19 pandemic. This novel coronavirus emerged in China, quickly spreading to more than 200 countries worldwide. Although most patients are only mildly ill or even asymptomatic, some develop severe pneumonia and become critically ill. One of the biggest unanswered questions is why some develop severe disease, whilst others do not. Insight on the interaction between SARS-CoV-2 and the immune system and the contribution of dysfunctional immune responses to disease progression will be instrumental to the understanding of COVID-19 pathogenesis, risk factors for worst outcome, and rational design of effective therapies and vaccines. In this review we have gathered the knowledge available thus far on the epidemiology of SARS-COV-2 infection, focusing on the susceptibility of older individuals, SARS-CoV-2-host cell interaction during infection and the immune response directed at SARS-CoV-2. Dendritic cells act as crucial messengers linking innate and adaptative immunity against viral infections. Thus, this review also brings a focused discussion on the role of dendritic cells and their immune functions during SARS-CoV-2 infection and how immune evasion strategies of SARS-CoV-2 and advancing age mediate dendritic cell dysfunctions that contribute to COVID-19 pathogenesis and increased susceptibility to worst outcomes. This review brings to light the hypothesis that concomitant occurrence of dendritic cell dysfunction/cytopathic effects induced by SARS-CoV-2 and/or aging may influence disease outcome in the elderly. Lastly, a detailed discussion on the effects and mechanisms of action of drugs currently being tested for COVID-19 on the function of dendritic cells is also provided.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available